Literature DB >> 1919170

MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

C O Jacob1, G D Lewis, H O McDevitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919170     DOI: 10.1007/bf02918162

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  47 in total

1.  Effects of interferon-gamma and tumor necrosis factor-alpha on the expression of an Ia antigen on a murine macrophage cell line.

Authors:  R J Chang; S H Lee
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases.

Authors:  L Fugger; N Morling; L P Ryder; J Georgsen; B K Jakobsen; A Svejgaard; V Andersen; P Oxholm; F Karup Pedersen; J Friis
Journal:  Tissue Antigens       Date:  1989-07

3.  Possible correlation of TNF alpha-production with -RFLP in humans.

Authors:  L Fugger; K Bendtzen; N Morling; L Ryder; A Svejgaard
Journal:  Eur J Haematol       Date:  1989-09       Impact factor: 2.997

4.  Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes.

Authors:  M C Carroll; P Katzman; E M Alicot; B H Koller; D E Geraghty; H T Orr; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes.

Authors:  A Waage; O Bakke
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

6.  Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.

Authors:  K Bendtzen; T Mandrup-Poulsen; J Nerup; J H Nielsen; C A Dinarello; M Svenson
Journal:  Science       Date:  1986-06-20       Impact factor: 47.728

7.  Tumor necrosis factor-alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages.

Authors:  M Hoffman; J B Weinberg
Journal:  J Leukoc Biol       Date:  1987-12       Impact factor: 4.962

8.  Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.

Authors:  T Mandrup-Poulsen; K Bendtzen; C A Dinarello; J Nerup
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

9.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.

Authors:  G E Nedwin; S L Naylor; A Y Sakaguchi; D Smith; J Jarrett-Nedwin; D Pennica; D V Goeddel; P W Gray
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

10.  Class-II and IL2 receptor positive cells in the pancreas of NOD mice.

Authors:  A Signore; A Cooke; P Pozzilli; G Butcher; E Simpson; P C Beverley
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

View more
  6 in total

1.  Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc.

Authors:  Fabian Richter; Oliver Seifert; Andreas Herrmann; Klaus Pfizenmaier; Roland E Kontermann
Journal:  MAbs       Date:  2019-03-31       Impact factor: 5.857

2.  Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.

Authors:  Melissa Pawelczak; Jamie Rosenthal; Sarah Milla; Ying-Hua Liu; Bina Shah
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-09-23       Impact factor: 1.814

Review 3.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Novel DNA polymorphism in the mouse tumor necrosis factor receptors type 1 and type 2.

Authors:  S Takao; K Mykytyn; C O Jacob
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Acute ethanol consumption synergizes with trauma to increase monocyte tumor necrosis factor alpha production late postinjury.

Authors:  G Szabo; P Mandrekar; B Verma; A Isaac; D Catalano
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

6.  The death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2-induced cell death.

Authors:  Nicole Cusson; Sarah Oikemus; Elizabeth D Kilpatrick; Leslie Cunningham; Michelle Kelliher
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.